Sign in
4

Changes in Ownership

PALISADE BIO, INC. Filed Acc 0001493152-26-032559

CEO, CFO sold 146,798 shares at $2.07 ($303,343)

  • CEO, CFO acquired 335,300 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Finley John David · CEO, CFO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-06 Exercise or conversion : show line 1 in the form +335,167 364,353 D
2026-07-07 Sale : show line 2 in the form −146,798 $2.07 $303,343 217,555 D
2026-07-07 Exercise or conversion : show line 3 in the form +133 $0.70 $93 217,688 D
Open-market sales · 146,798 sh · avg $2.07 · $303,343

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-07-06 Exercise or conversion : show line 4 in the form Restricted Stock Units −335,167 1,675,833 D
2026-07-07 Exercise or conversion : show line 5 in the form Series 2 Common Stock Purchase Warrant −133 0 D
Loading xslF345X06/ownership.xml…